entertainment -WSS

entertainment

author：fashion 2025-09-29 16:21:20 - browse：78414

SAN DIEGO — One of the toughest subtypes of acute leukemia involves a genetic alteration in the KMT2A gene. Many cancers with this genetic alteration end up relapsing or don’t respond to treatment, but new data presented at the annual American Society of Hematology meeting offer hope of a new targeted therapy for these patients.

The study, called the Phase 2 Augment-101 trial, tested Syndax’s revumenib in patients with relapsed or refractory leukemia with these KMT2A genetic rearrangements. Overall, about 63% of the patients responded to the treatment, with many able to receive a potentially curative stem cell transplant later on, which is often the ultimate goal for patients with relapsed or refractory patients, said Ibrahim Aldoss, a hematologist-oncologist at City of Hope and the study’s presenter, in an interview.

“KMT2A-rearranged diseases represent 10% of all leukemia. They can be exceptionally hard to treat,” Aldoss said. “The median overall survival remains low with current available treatment. Right now there’s no targeted therapy for KMT2A-rearranged disease. We’re really excited about revumenib as it targets the mutation, and we’re seeing encouraging outcomes.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Stanford updates investigation of president’s past research

WSS

India sets sights on home

Stanford updates investigation of president’s past research

Spinal cord stimulation reduces pain in amputees, study finds

The woman behind the Dana Farber

Radiology is caught between AI's potential and concern for patients

Radiology is caught between AI's potential and concern for patients

leisure time

entertainment

leisure time

Psychedelics group wrestles with new pharma identity

Roche to buy Carmot Therapeutics, developer of obesity drugs

Malaria cases in Florida and Texas: Here’s what you need to know

India sets sights on home

Affirmative action in medical school literally saved lives

Pregnancy discrimination could be enabled by AI

Affirmative action in medical school literally saved lives

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA approves world's first CRISPR

Wikipedia

Stanford president to resign after investigation of research

AI models in health care face new federal disclosure requirements

Teach medical students about patients with intellectual disabilities

Pharma patents targeted by Biden in move to slash drug prices

Chemotherapy shortages won’t get better under Biden’s latest plan

Medical experts are missing from AI regulatory conversations

knowledge

hotspot

entertainment

knowledge